Preclinical models of maternal asthma and progeny outcomes: a scoping review protocol
JBI Evidence Synthesis · 2023
DOI: 10.11124/jbies-23-00006 ↗Kurz gefasst
Scoping Review in der Zeitschrift JBI Evidence Synthesis, 2023. Verfasst von Joshua L Robinson und 4 weiteren Autor:innen. Beteiligte Einrichtung: Robinson Research Institute, The University of Adelaide, Adelaide, SA, Australia. Hauptthemen laut MEDLINE: Premature Birth, Pre-Eclampsia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben.
Abstract (Originalsprache)
Objective
This scoping review will describe the methodology, phenotype, and characteristics of maternal asthma models used in preclinical studies and the outcomes that have been measured in the mother and progeny. The review This will identify gaps in knowledge of maternal and progeny outcomes following maternal asthma in pregnancy.
Introduction
Maternal asthma affects up to 17% of pregnancies worldwide and is associated with adverse perinatal outcomes in mothers and babies, including pre-eclampsia, gestational diabetes, cesarean section, preterm birth, small for gestational age, nursery admission, and neonatal death. While the associations are well established, the mechanisms linking maternal asthma and adverse perinatal outcomes are largely unknown due to the difficulties of human mechanistic studies. The appropriate selection of animal models is vital to understanding the mechanisms underlying associations between human maternal asthma and adverse perinatal outcomes. Inclusion criteria: This review will include primary studies published in English where outcomes have been studied in vivo in non-human mammalian species.
Methods
This review will follow the JBI methodology for scoping reviews. We will search MEDLINE (PubMed), Embase, and Web of Science to identify papers published before the end of 2022. Initial keywords will include pregnancy, gestation, asthma , and wheeze , as well as validated search strings to identify papers that describe animal models. Extracted data will include information on methods used to induce maternal asthma; asthmatic phenotypes and characteristics; and maternal, pregnancy, placental, and progeny outcomes. The characteristics of each study will be presented in summary tables and a core outcome list to assist researchers in developing, reporting, and comparing future animal studies of maternal asthma. Review registration: Open Science Framework osf.io/trwk5
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Robinson Research Institute, The University of Adelaide, Adelaide, SA, Australia.
- Adelaide Medical School, The University of Adelaide, Adelaide, SA, Australia.
- Early Origins of Adult Health Research Group, Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia, Adelaide, SA, Australia.
- School of Biomedicine, The University of Adelaide, Adelaide, SA, Australia.
- Mater Research Institute, University of Queensland, Brisbane, QLD, Australia.
- Department of Neonatal Medicine, Women's and Children's Hospital, Adelaide, SA, Australia.
ORCID-Profile: Joshua L Robinson, Vicki L Clifton
Zitieren
APA
Robinson, J. L., Gatford, K. L., Clifton, V. L., Morrison, J. L., & Stark, M. J. (2023). Preclinical models of maternal asthma and progeny outcomes: a scoping review protocol. JBI Evidence Synthesis. https://doi.org/10.11124/jbies-23-00006
Vancouver
Robinson JL, Gatford KL, Clifton VL, Morrison JL, Stark MJ. Preclinical models of maternal asthma and progeny outcomes: a scoping review protocol. JBI Evidence Synthesis. 2023. doi:10.11124/jbies-23-00006
BibTeX
@article{Robinson2023,
author = {Robinson, Joshua L and Gatford, Kathy L and Clifton, Vicki L and Morrison, Janna L and Stark, Michael J},
title = {Preclinical models of maternal asthma and progeny outcomes: a scoping review protocol},
journal = {JBI Evidence Synthesis},
year = {2023},
doi = {10.11124/jbies-23-00006}
}
EUVIMED